Sherry Levine, MD
Otolaryngology · Pembroke Pines, FLNPI 1568647196
Payments from drug & device makers
Across 94 payments — averaging $72.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$4K
- Aerin Medical Inc.$387
- Mentor Worldwide LLC$380
- Medtronic$345
- Regeneron Healthcare Solutions, Inc.$334
- GSK$334
- plus $650 from 10 others
What the payments were for
- Consulting fees$3,00044%
- Travel & lodging$78712%
- Food & beverage$3,01244%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 20 | $4,368 |
| Aerin Medical Inc. | 10 | $387 |
| Mentor Worldwide LLC | 3 | $380 |
| Medtronic | 7 | $345 |
| Regeneron Healthcare Solutions, Inc. | 12 | $334 |
| GSK | 18 | $334 |
| Sanofi | 8 | $212 |
| Genentech USA, Inc. | 2 | $151 |
| Alk-abello, Inc | 5 | $106 |
| Smith+Nephew | 2 | $39 |
| Inspire Medical Systems, Inc. | 2 | $35 |
| Neurent Medical Limited | 1 | $28 |
| Stryker | 1 | $25 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $22 |
| Acell, Inc. | 1 | $16 |
| Hikma Pharmaceuticals USA | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,798 in reported general payments places this provider in the 80th percentile of 586 otolaryngology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 108 | $2,957 |
| Fluticasone Propionate | 138 | $2,041 |
| Dexamethasone Sodium Phosphate | 44 | $1,764 |
| Azelastine Hcl | 42 | $1,627 |
| Ofloxacin | 41 | $979 |
| Fluocinolone Acetonide Oil | 16 | $670 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 11 | $537 |
| Levocetirizine Dihydrochloride | 30 | $511 |
| Omeprazole | 42 | $488 |
| Mometasone Furoate | 39 | $417 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 11 | $414 |
| Famotidine | 51 | $378 |
| Mupirocin | 56 | $372 |
| Triamcinolone Acetonide | 12 | $355 |
| Doxycycline Hyclate | 41 | $286 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Pembroke Pines
- Sina JoorabchiPembroke Pines$76K
- Carlos TorrePembroke Pines$44K
- Craig ShapiroHollywood$8.1M
- Adrien EshraghiMiami$2.1M
- Cecelia DamaskOrlando$771K
- Ralph TufanoSarasota$733K
- Mitchell MillerClearwater$709K
- Brian KerrGainesville$629K
- Maria SuurnaMiami$456K
- Mark TaborTampa$348K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.